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Abstract
Rapid eye movement (REM) sleep is a distinct brain state characterized by activated 
electroencephalogram (EEG) and complete skeletal muscle paralysis, and it is associated with 
vivid dreams1-3. Transection studies by Jouvet first demonstrated that the brainstem is both 
necessary and sufficient for REM sleep generation2, and the neural circuits in the pons have since 
been studied extensively4-8. The medulla also contains neurons that are active during REM 
sleep9-13, but whether they play a causal role in REM sleep generation remains unclear. Here we 
show that a GABAergic pathway originating from the ventral medulla (vM) powerfully promotes 
REM sleep. Optogenetic activation of vM GABAergic neurons rapidly and reliably initiated REM 
sleep episodes and prolonged their durations, whereas inactivating these neurons had the opposite 
effects. Optrode recordings from channelrhodopsin 2 (ChR2)-tagged vM GABAergic neurons 
showed that they were most active during REM sleep (REM-max), and during wakefulness they 
were preferentially active during eating and grooming. Furthermore, dual retrograde tracing 
showed that the rostral projections to the pons and midbrain and caudal projections to the spinal 
cord originate from separate vM neuron populations. Activating the rostral GABAergic projections 
was sufficient for both the induction and maintenance of REM sleep, which are likely mediated in 
part by inhibition of REM-suppressing GABAergic neurons in the ventrolateral periaqueductal 
gray (vlPAG). These results identify a key component of the pontomedullary network controlling 
REM sleep. The capability to induce REM sleep on command may offer a powerful tool for 
investigating its functions.
Previous studies showed that the vM contains GABAergic neurons expressing the immediate 
early gene c-fos following deprivation-induced REM sleep rebound11,12, suggesting REM 
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sleep-related activity. To test the causal relationship between vM GABAergic neuron activity 
and brain states, we injected Cre-inducible adeno-associated viruses (AAV) expressing 
ChR2-eYFP locally into the vM of GAD2-Cre mice (Fig. 1a). Laser stimulation (20 Hz, 120 
s/trial) was applied every 15-20 min, and brain states – wake, REM and non-REM (NREM) 
sleep – were classified based on EEG and electromyogram (EMG) recordings. REM sleep 
was observed at a high probability during laser stimulation (Fig. 1b and Supplementary 
Video 1). To quantify the effect, we aligned all trials from 6 mice by the time of laser 
stimulation (Fig. 1c). We found a rapid, ~12 fold increase in REM sleep within 30 s of laser 
onset (P<0.001, bootstrap) and a complementary decrease of NREM sleep. The EEG power 
spectrum and EMG activity during the laser-induced REM state were indistinguishable from 
those during spontaneous REM sleep outside of laser stimulation periods (Extended Data 
Fig. 1). In control mice expressing eYFP without ChR2, laser had no effect (Extended Data 
Fig. 2), and the laser-induced change in REM sleep probability was significantly different 
between the ChR2 and control mice (P<0.001, bootstrap). Furthermore, ChR2-mediated 
activation of vM glutamatergic neurons reliably induced wakefulness rather than REM sleep 
(Extended Data Fig. 3), indicating that the REM-promoting effect was specific to 
GABAergic neurons.
The complementary changes in REM and NREM probabilities (Fig. 1c) suggest that vM 
GABAergic neuron activation primarily triggered NREM→REM transitions. To test this 
possibility, we analyzed the effect of laser on the transition probability between each pair of 
brain states. Laser stimulation markedly enhanced the NREM→REM transitions (P=0.02, 
bootstrap; Extended Data Fig. 4a). As a result, for trials in which laser onset fell on NREM 
sleep, the probability of REM sleep increased to 85% within 50 s (Fig. 1d), and 
NREM→REM transitions occurred in 94% of these trials. Notably, laser stimulation caused 
no significant change in NREM→wake (P=0.24) and a reduction in REM→wake (P<0.001) 
transition probability (Extended Data Fig. 4b, c). Thus the gradual increase of wakefulness 
during laser stimulation (Fig. 1c, purple) was not due to a direct induction of wakefulness, 
but a secondary consequence of laser-induced increase in REM sleep (in rodents REM sleep 
periods are often shorter than 120 s and typically followed by wakefulness). Furthermore, 
direct wake→REM transitions, characteristic of narcolepsy, were not observed (Extended 
Data Fig. 4e), indicating that optogenetic activation of vM GABAergic neurons triggered 
normal but not pathological transitions into REM sleep. This also explains why in trials in 
which laser was turned on during wakefulness, no increase in REM sleep was observed (Fig. 
1e, Trial 3 in Supplementary Video 1).
To test whether these neurons also contribute to REM sleep maintenance, we applied a 
closed-loop protocol14, in which laser stimulation was initiated after spontaneous REM 
sleep onset and maintained throughout the REM episode (Fig. 2a). The stimulation was 
applied randomly in ~50% of the episodes, and REM duration was compared between the 
episodes with and without stimulation (Fig. 2b). Laser stimulation increased the mean 
duration of REM episodes by 111% in GAD2-ChR2 mice (laser, 148.0±19.2 s, s.d.; no laser, 
70.2±10.1 s; P=0.00037, paired t-test, n=6 mice) but not in eYFP control mice (laser, 
77.0±14.9 s; no laser, 83.8±13.6 s; P=0.62, n=4; Fig. 2c). Conversely, archaerhodopsin 
(Arch) or halorhodopsin (Halo)-mediated silencing of vM GABAergic neurons (green laser) 
caused a 41% reduction of REM duration (laser, 54.1±9.8 s, s.d.; no laser, 91.2±11.7 s; 
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P=0.001, n=4), an effect not observed in eYFP control mice (laser, 90.0±12.9 s; no laser, 
79.5±9.6 s; P=0.075, n=4, Fig. 2d). Thus, vM GABAergic neuron activity also contributes 
strongly to REM sleep maintenance. In addition, we pharmacogenetically silenced vM 
GABAergic neurons by expressing hM4Di15. Compared to vehicle injection, inhibition of 
these neurons by clozapine-N-oxide (CNO) injection strongly reduced REM sleep in a dose-
dependent manner (Extended Data Fig. 5), further indicating the importance of vM 
GABAergic neurons in REM sleep generation.
Although vM GABAergic neurons have been shown to express c-fos following deprivation-
induced REM sleep rebound11,12, the slow time course of c-fos expression and its 
modulation by non-activity-related factors16 limit its precision in identifying REM-active 
neurons. To understand how vM GABAergic neurons regulate REM sleep under natural 
conditions, we recorded their spiking activity across brain states. Since the vM contains 
multiple spatially intermingled cell types17, we tagged the GABAergic neurons with ChR2 
by crossing GAD2-Cre with ChR2 reporter (Ai 32) mice. Recordings were made in freely 
moving mice using optrodes, consisting of an optic fiber surrounded by multiple 
microelectrodes. High-frequency laser pulses (15 or 30 Hz) were applied intermittently, and 
single units exhibiting reliable laser-evoked responses with short latencies and low jitter 
were identified as GABAergic neurons (Fig. 3a-c and Extended Data Fig. 6a). The identified 
neurons consistently fired at high rates during REM sleep, low rates during NREM sleep, 
and variable rates during wakefulness9 (Fig. 3d and Supplementary Video 2). When the 
firing rates were averaged within each state, all 20 identified GABAergic neurons were most 
active during REM sleep (P<0.005, Wilcoxon rank sum test; Fig. 3e-g, referred to as “REM-
max” neurons). The mean firing rate of these neurons during REM sleep (34.6 spikes/s, 95% 
confidence interval (CI): 23.6 – 48.0 spikes/s) was in fact higher than the laser stimulation 
frequency applied in our experiments (Figs. 1 and 2), suggesting that their activity is 
sufficient for the observed REM promoting effects. Their firing rates increased gradually 
over ~30 s before the NREM→REM transition and decreased abruptly at the end of REM 
sleep (Extended Data Fig. 7). Such a temporal profile is well suited for both the induction 
and maintenance of REM sleep.
Since during wakefulness the firing rates of vM GABAergic neurons were highly variable, 
we analyzed their relationship with different wakeful behaviors (classified based on video 
recordings, Supplementary Video 2). Of the 17 identified GABAergic neurons with 
recording periods encompassing multiple behaviors, 82% were most active during eating 
(n=8) or grooming (n=6) and much less active during moving or running (Fig. 3h and 
Extended Data Fig. 6c). Such a firing pattern is distinct from that of noradrenergic neurons 
in the locus coeruleus (a known postsynaptic target of vM GABAergic neurons18), which are 
strongly suppressed during eating and grooming19. Interestingly, activation of vM 
GABAergic neurons during wakefulness increased eating (Extended Data Fig. 8), indicating 
a causal relationship between their firing and the eating behavior. Among the 24 unidentified 
neurons recorded in the vM (likely to include non-GABAergic neurons), 71% were also 
REM-max9,10,13 (Extended Data Fig. 9a, b). Compared to the identified GABAergic 
neurons, however, the unidentified group showed a delayed firing rate increase before REM 
sleep onset (~10 s) and a more gradual decrease at REM termination (Extended Data Fig. 9c, 
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d). In addition, many of them were most active during running or moving (Extended Data 
Fig. 9b, right).
Previous studies showed that vM neurons project both rostrally to the pons, midbrain, and 
other brain regions and caudally to the spinal cord13,20. We wondered which pathway 
mediates the REM-promoting effect. The pons and midbrain are known to be crucial for 
REM sleep generation2,4,6-8,12. Injection of Cre-inducible AAV expressing ChR2-eYFP into 
the vM of GAD2-Cre mice revealed extensive axon projections to these regions (Fig. 4a). In 
particular, the vlPAG is thought to suppress REM sleep by providing GABAergic inhibition 
to REM-promoting neurons7,12. To test the effect of vlPAG GABAergic neuron activity on 
brain states, we injected Cre-inducible AAV expressing ChR2-eYFP into the vlPAG of 
GAD2-Cre mice. Laser stimulation almost completely suppressed REM sleep onset 
(P<0.001, bootstrap, n=6) and shortened REM episode duration (laser, 37.1±10.2 s, s.d.; no 
laser, 82.8±9.9 s; P=0.003, paired t-test, n=5) while strongly promoting NREM sleep 
(P<0.001, bootstrap; Fig. 4c). Rabies virus–mediated monosynaptic retrograde tracing 
confirmed that vlPAG GABAergic neurons receive direct inhibitory innervation from vM 
neurons (Fig. 4d, e). Furthermore, optogenetic activation of vM GABAergic neuron axons 
within the vlPAG caused large increases in both the initiation (P<0.001, bootstrap, n=5) and 
duration (laser, 130.7±32.9 s, s.d.; no laser, 59.6±9.6 s; P=0.02, paired t-test, n=5) of REM 
sleep episodes (Fig. 4f), with magnitudes comparable to those found with vM cell body 
stimulation (Figs. 1 and 2). Although in principle axon fiber stimulation in the vlPAG could 
antidromically activate neuronal cell bodies in the vM and axon collaterals to other regions, 
simultaneous injections of retrograde tracers to both the pons and spinal cord showed little 
overlap between the labeled neurons (1.3%, Fig. 4b), indicating that the rostral and caudal 
projections arise largely from separate vM neuron populations. Thus, the rostral projections 
from vM GABAergic neurons exert a strong REM sleep-promoting effect, likely mediated at 
least in part by direct inhibition of the REM-suppressing vlPAG GABAergic neurons.
Although the medulla is known to be involved in REM sleep generation, previous studies 
have focused primarily on its role in inducing muscle atonia, through projections to the 
spinal cord21,22. Our findings indicate that vM GABAergic neurons constitute a critical 
component of the core network, generating not only muscle atonia but also the cortical 
activation associated with REM sleep17,23,24. The effect is largely, if not completely, 
attributable to the rostral projections (Fig. 4), consistent with the previous finding that 
inactivation of the pons or transection at the pontomedullary junction blocks the muscle 
atonia evoked by medulla stimulation25,26. The projection to the locus coeruleus is likely to 
provide GABAergic inhibition of noradrenergic neurons13,18, whose activity enhances 
wakefulness27 and spinal motor neuron excitability28. Inhibition of the vlPAG GABAergic 
neurons (Fig. 4c) should cause disinhibition of the REM-promoting neurons in the 
pons5-8,12, which may in turn trigger muscle atonia through their projections to the medulla 
and spinal cord, and cortical activation through their projections to midbrain and forebrain 
regions. The glutamatergic REM-active neurons in the dorsal pons6 may also innervate the 
vM GABAergic neurons13, thus shaping their firing rates across different brain states (Fig. 
3).
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In addition to the vM, the dorsal medulla also contains REM-max GABAergic neurons 
projecting to the locus coeruleus29, which may also contribute to REM sleep generation. The 
induction of NREM→REM but not wake→REM transitions by vM neurons points to a 
robust wake maintenance mechanism – likely to involve orexin/hypocretin neurons30 – that 
cannot be overridden by activating the vM GABAergic neurons. How this mechanism 
interacts with the REM sleep generation circuit remains to be elucidated. Furthermore, a 
long-standing mystery is what functions are served by REM sleep and its associated 
dreaming. The ability to control REM sleep at a high temporal precision, as demonstrated in 
this study, provides a powerful tool for studying its functions.
METHODS
Animals
All experimental procedures were approved by the Animal Care and Use Committee at the 
University of California, Berkeley. Optogenetic manipulation experiments were performed 
in male or female GAD2-Cre (Jackson Lab stock #010702) and VGLUT2-Cre (#016963) 
mice. Pharmacogenetic, rabies-mediated transsynaptic tracing and anterograde tracing 
experiments were performed in male or female GAD2-Cre mice. For optrode recording 
experiments, male GAD2-Cre mice were crossed with female loxP-flanked-ChR2-eYFP 
mice (#012569). Retrograde tracing experiments with RetroBeads (Lumafluor) and 
FluoroGold (Fluorochrome) were carried out in male or female wild-type (C57) mice.
Surgery
Adult (6 - 12 week old) mice were anesthetized with isoflurane (3% induction, 1.5% 
maintenance) and placed on a stereotaxic frame. Body temperature was kept stable 
throughout the procedure using a heating pad. After asepsis, the skin was incised to expose 
the skull, and the overlying connective tissue was removed. For optogenetic experiments, a 
craniotomy (~1 mm diameter) was made above the right cerebellum (6.8 mm posterior to 
bregma, 0.6-0.9 mm lateral). Virus (AAV2-EF1α-FLEX-ChR2-eYFP, AAV2-EF1α-FLEX-
eYFP, AAV2-EF1α-FLEX-eNpHR3.0-EYFP, AAV2-CAG-FLEX-ArchT-tdTomato, 
produced by University of North Carolina Vector Core, or AAV-DJ-EF1α-FLEX-ChR2-
eYFP) was loaded into a sharp micropipette mounted on a Nanoject II and injected slowly at 
a depth of 4.8 mm from brain surface (600-800 nL). An optical fiber (200 μm diameter) was 
inserted with the tip ~ 400 μm above the virus injection site. To stimulate axon projections of 
vM GABAergic neurons in the vlPAG, the optical fiber was implanted on top of the vlPAG 
(4.8 mm posterior to bregma, 0.6 mm lateral, 2.3 mm depth). To activate vlPAG GABAergic 
neurons, AAV expressing ChR2-eYFP was injected into the vlPAG. For pharmacogenetic 
experiments, AAV8-hSyn-FLEX-hM4D(Gi)-mCherry was injected bilaterally (300-800 nL 
on each side). For EEG and EMG recordings, a reference screw was inserted into the skull 
on top of the left cerebellum. EEG recordings were made from two screws on top of the left 
and right cortex (1 mm posterior to bregma). Two EMG electrodes were inserted into the left 
and right neck muscles. The optical fiber, screws, and EEG/EMG electrodes were secured to 
the skull using dental cement. Without optogenetic manipulation, the sleep architecture 
quantified by the percentage, average duration and frequency of each brain state of these 
implanted animals is well within the range reported for mice without these implants, 
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indicating that virus injection and optic fiber implantation did not cause large chronic 
changes in sleep architecture. For optogenetic experiments, data from animals where the tip 
of the optic fiber was not within the aimed location were excluded. For pharmacogenetic 
experiments, data from animals where virus expression was not restricted to the vM were 
excluded.
For optrode recording experiments, the optrode assembly was inserted at a depth of 4.8 mm. 
A screw was attached to the frontal skull for EEG recording, and an EMG electrode was 
inserted into the right neck muscle. The optrode assembly, screws, and EEG/EMG 
electrodes were secured to the skull using dental cement.
For rabies-mediated retrograde tracing experiments, we first injected 100-150 nL of a 
combination of AAV5-CAG-FLEX-TCB (2.6 × 1012 vector genomes/mL) and AAV8-CAG-
FLEX-RG (1.3 × 1012 vector genomes/mL)31 (addgene #48332 and #48333, respectively) 
into the vlPAG (4.8 mm posterior to bregma, 0.6 mm lateral, 2.5 mm depth) of GAD2-Cre 
mice.
Three weeks later, RVdG (titer 5 × 108 colony forming units/mL) pseudotyped with EnvA 
was injected into the vlPAG. AAV5-CAG-FLEX-TCB and AAV-CAG-FLEX-RG were 
purchased from the University of North Carolina viral core, and RVdG was amplified in 
house from a stock derived from the Salk Institute viral core. Data from mice where starter 
cells were found outside the vlPAG were excluded. For controls, we injected the same 
viruses in the same temporal sequence into wild-type mice (n=2). No GFP-labeled cells 
were detected in the vM.
For dual retrograde tracing experiments, we injected RetroBeads bilaterally into the pons 
(5.0-5.2 mm posterior to bregma, 0.9 mm lateral) at several depths (3.0, 3.5, and 4.0 mm, 
150-200 nl at each depth). The spinal cord was exposed by a unilateral laminectomy of a 
cervical vertebra. After a small incision in the dura, FluoroGold was injected (0.7 mm 
lateral, 1 mm depth, 400-700 nl). Histology and in vivo experiments were performed >10 
and >21 days after injection.
Polysomnographic recordings
Animals were housed on a 12-hr dark/12-hr light cycle (light on between 7:00 and 19:00). 
Behavioral experiments were carried out between 13:30 and 18:30. EEG and EMG 
electrodes were connected to flexible recording cables via a mini-connector, and recordings 
were made in the animal's home cage placed in a sound-attenuation box. Recordings started 
after >1 hr of habituation. The signals were recorded with a TDT RZ5 amplifier, filtered 
(1-750 Hz) and digitized at 1500 Hz. Brain states were classified into NREM sleep, REM 
sleep, and wakefulness using a custom-written MATLAB software. The classification was 
performed without any information regarding the identity of the animal or laser stimulation 
timing. First, we calculated the power spectrum of the EEG and EMG using a 5 s sliding 
window, sequentially shifted by 2.5 s increments. Next, we summed the EEG power in the 
ranges from 1 to 4 Hz and from 6 to 12 Hz, yielding a time dependent delta and theta power, 
respectively. For further analysis, we divided the theta by the delta power (theta/delta ratio). 
We also computed the total EMG power from 20 to 300 Hz. For each time point, we 
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determined the brain state using a threshold algorithm. A state was classified as NREM if 
the delta power was lower than its mean (averaged over the whole recording session) and if 
the EMG power was lower than its mean plus one standard deviation. A state was classified 
as REM if (1) the delta power was lower than the average, (2) the theta/delta ratio deviated 
more than one standard deviation from its mean, and (3) the EMG power was lower than its 
mean plus one standard deviation. All remaining states were classified as wake. The wake 
state thus encompassed states with high EMG power (active awake), or low delta power 
without elevated EMG activity or theta/delta ratio (quiet awake). Finally, we manually 
verified the automatic classification to ensure that all states were correctly assigned.
Behavioral monitoring
To classify different wakeful behaviors, we made video recordings (sampling rate, 5 Hz) 
using a camera placed on top of the cage. Wakeful behaviors were divided into four 
categories: eating, grooming, moving, and running. The classification was performed 
manually, based on the video, EEG, and EMG recordings, using a custom-written graphical 
user interface (programmed in MATLAB). The experimenter classifying the wakeful 
behaviors was blind to the timing of laser stimulation or the identity of the animal.
Optogenetic manipulation
For optogenetic experiments, the experimenter randomly assigned mice to the control group 
or one of the experimental groups. Experimental and control animals were subjected to 
exactly the same surgical and behavioral manipulations. To test the role of vM GABAergic 
neurons in REM sleep induction, we applied blue laser stimulation (473 nm, 5 mW at fiber 
tip) at 20 Hz (10 ms/pulse). Each trial lasted for 120 s (stimulation of vM GABAergic 
neurons and axon projections) or 300 s (stimulation of vlPAG GABAergic neurons), and the 
inter-trial interval was chosen randomly from a uniform distribution between 15 and 25 min. 
For each animal we recorded at least two 5-hr sessions.
To test the role of vM or vlPAG GABAergic neurons in REM sleep maintenance, we applied 
a closed-loop stimulation protocol. The animal's brain state was classified by real-time 
analysis of EEG/EMG recordings. As soon as REM sleep was detected, the laser was turned 
on with 50% probability, and turned off only when the REM episode ended. This allowed 
comparison of the durations of REM episodes with and without laser stimulation within the 
same recording session. REM periods were assigned to either the experimental or control 
group according to a pseudo-random Bernoulli sequence generated before the start of the 
experiment. For each animal at least two 5 hr sessions were recorded. In ChR2-mediated 
activation experiments, we used a blue laser (473 nm, 5 mW, 20 Hz). In Arch/Halo-mediated 
inhibition experiments, we used a green laser (532 nm, 20 mW, step pulse).
Pharmacogenetic manipulation
To inhibit vM GABAergic neurons, we injected clozapine N-oxide (CNO) dissolved in 0.1 
ml vehicle solution (PBS with 0.5% DMSO) into GAD2-Cre mice expressing hM4Di in the 
vM, 20 min prior to the recording session. CNO was administered intraperitoneally at two 
doses (1 and 5 mg/kg body weight) on different days. For the control experiment, we 
injected the vehicle solution without CNO.
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Optrode recording
To record the activity of vM GABAergic neurons, we used a custom-built optrode32, 
consisting of an optical fiber (0.1 or 0.2 mm diameter) surrounded by 12 microwire 
electrodes (Stablohm 675) twisted into stereotrodes or tetrodes. The electrode tips were 
electroplated in a chloride-platinum solution to an impedance of ~600 kΩ. The optical fiber 
and electrodes were inserted into a screw-driven microdrive. The optrode was slowly 
lowered in 25 to 50 μm steps to search for light-responsive neurons. The signals were 
recorded using a TDT RZ5 amplifier, filtered (0.3-8 kHz) and digitized at 25 kHz. 
Recordings were carried out over a period of 1-2 months from each mouse. At the end of the 
experiment electrolytic lesions were made by passing a current (100 μA, 10 s) through one 
or two electrodes to identify the end of the recording tract.
Spike sorting—Spikes were sorted offline based on the waveform energy and the first 
three principal components of a spike waveform on each stereotrode or tetrode channel. 
Single units were identified either manually using the software Klusters (http://
neurosuite.sourceforge.net) or automatically using the software klustakwik (http://
klustakwik.sourceforge.net). The quality of each unit was assessed by the presence of a 
refractory period and quantified using isolation distance and L-ratio33. Units with an 
isolation distance <19 or L-ratio >0.1 were discarded. For units recorded with stereotrodes, 
the median values of isolation distance and L-ratio were 34.4 and 0.001. For units recorded 
with tetrodes, the corresponding median values were 38.3 and 0.023.
Identification of GABAergic units—To identify ChR2-expressing vM GABAergic 
neurons, high-frequency laser pulse trains (15 and 30 Hz with duration of 1 and 0.5 s, 
respectively) were delivered every one or two min. The laser power and pulse duration were 
optimized to identify light-responsive neurons without changing the brain state. A unit was 
identified as GABAergic if spikes were evoked by laser pulses (both 15 and 30 Hz trains) at 
high reliability (>0.6), short first-spike latency (<6 ms), and small jitter (<2 ms), and if the 
waveforms of the laser-evoked and spontaneous spikes were highly similar (correlation 
coefficient >0.9; Extended Data Fig. 6a). To compute the mean firing rate of each neuron in 
each brain state, spikes during the laser pulse trains were excluded. Twenty out of 21 
identified GABAergic units had their recording periods encompassing all three brain states. 
For 17 units the recording periods encompassed all four wakeful behaviors.
In total we recorded from 21 identified GABAergic units and 24 unidentified units. 
However, the ratio (21/24) is likely affected by sampling bias and thus may not reflect the 
actual percentage of ChR2-labeled GABAergic neurons in the vM. In general, the success 
rate for finding a neuron that is reliably activated by laser is very low. To maximize the rate 
of data collection from identified neurons, we spent the 1-2 hrs on recording (instead of 
moving the electrode to a new location) only if we found at least one unit that appeared to be 
activated by the laser pulses. As a result, most of the unidentified units were recorded 
simultaneously with other laser-driven, putative GABAergic units.
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Histology and immunohistochemistry
Mice were deeply anesthetized and transcardially perfused with 0.1 M PBS followed by 4% 
paraformaldehyde (wt/vol) in PBS. For fixation, brains stayed overnight in 4% 
paraformaldehyde. For cryoprotection, brains were placed in 30% sucrose (wt/vol) in PBS 
solution for at least two nights. After embedding and freezing, brains were sectioned into 20, 
30 or 60 μm coronal slices using a cryostat. For immunohistochemistry, non-specific binding 
sites were blocked by incubating the sections in 2% donkey or goat serum in PBST (0.3% 
Triton X-100 in PBS). Brain sections were stained with an anti-choline acetyltransferase 
antibody (AB144, Millipore; 1:250) for cholinergic neurons, and anti-glycine (AB5020, 
Millipore, 1:100) for glycinergic neurons. To amplify the fluorescence of axon fibers 
expressing ChR2-eYFP, we used an antibody against GFP (A11122 or A11120, Life 
technologies, 1:1000). Brain sections were incubated with the primary antibody in blocking 
solution for two nights. Species-specific secondary antibodies conjugated with red or green 
Alexa fluorophores (donkey anti-mouse, A21202, 1:1000; goat anti-rabbit, A11008, 1:1000; 
donkey anti-goat, A11058, 1:250) in PBS were applied for 2 hrs. Finally, slides were washed 
for 2 hrs in PBS and mounted with Fluoromount. Fluorescence images were taken using a 
confocal microscope (LSM 710 AxioObserver Inverted 34-Channel Confocal) and 
Nanozoomer.
Statistics
All statistical tests (paired t-test, Wilcoxon rank sum test, Wilcoxon signed-rank test, 
bootstrap) were two-sided. For both paired and unpaired tests, we ensured that the variance 
of the data is similar between the compared groups. For t-tests, we verified that the data are 
normally distributed using Lilliefors test for normality.
The 95% confidence intervals (CI) for brain state probabilities were calculated using a 
bootstrap procedure: For an experimental group of n mice, with mouse i comprising mi 
trials, we calculated the CI as follows: we repeatedly resampled the data by randomly 
drawing for each mouse mi trials (random sampling with replacement). For each of the 
10,000 iterations, we recalculated the mean probabilities for each brain state across the n 
mice. The lower and upper confidence intervals were then extracted from the distribution of 
the resampled mean values. To test whether a given brain state is significantly modulated by 
laser stimulation, we calculated for each bootstrap iteration the difference between the mean 
probabilities during laser stimulation and the preceding period of identical duration. From 
the resulting distribution of difference values, we then calculated a P-value to assess whether 
laser stimulation significantly modulated the brain state.
Samples sizes
To determine the sample sizes of the experimental groups for optogenetic and 
pharmacogenetic experiments, for each group we first performed pilot experiments with two 
or three mice. Given the strength of the effect and the variance across this group, we then 
predicted the number of animals required to reach sufficient statistical power. To determine 
the sample size (number of units) for optrode recordings, we first recorded from two 
animals. Given the success rate of finding identified units and the homogeneity of units in 
the initial data set, we set a target sample size of 20 units. For rabies-mediated, anterograde, 
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or dual retrograde tracing experiments the selection of the sample size was based on 
numbers reported in previous studies.
Extended Data
Extended Data Figure 1. Comparison of spontaneous and laser-induced REM sleep
a, Mean EEG spectrogram and EMG amplitude before and after laser onset (averaged across 
all trials with laser onset falling on NREM sleep). b, Mean EEG spectrogram and EMG 
amplitude before and after spontaneous REM onset outside of laser stimulation periods 
(only REM episodes with duration >70 s were included). c, Comparison of EEG power 
spectra during spontaneous (gray) and laser-induced (blue) REM sleep. Blue shading, 
±s.e.m. for laser-induced REM sleep.
Extended Data Figure 2. Effect of laser stimulation on brain states in eYFP control mice
a, Brain states in all trials from 5 mice aligned by time of laser stimulation (top) and 
probability of wake, NREM or REM states before, during, and after laser stimulation 
(bottom). Shading, 95% confidence intervals (CI). Blue bar, period of laser stimulation. 
Laser stimulation caused no significant change in the probability of any brain state (P > 
0.34, bootstrap). b, Similar to (a), for trials in which laser onset fell on NREM sleep. c, 
Trials in which laser onset fell on wakefulness.
Weber et al. Page 10
Nature. Author manuscript; available in PMC 2016 May 02.
H
H
M
I A
uthor M
an
u
script
H
H
M
I A
uthor M
an
u
script
H
H
M
I A
uthor M
an
u
script
Extended Data Figure 3. Optogenetic activation of vM glutamatergic neurons induces 
wakefulness
a, Probability of wake, NREM or REM states before, during, and after laser stimulation (20 
Hz, 120 s) in VGLUT2-Cre mice injected with AAV expressing ChR2-eYFP into the vM 
(n=3 mice). Shading, 95% CI. Blue bar, period of laser stimulation. Laser stimulation caused 
a significant increase in wakefulness (P<0.001, bootstrap) and decrease in NREM sleep 
(P<0.001). b, Mean durations of REM sleep episodes with and without laser stimulation. 
Each pair of dots represent data from one mouse. Laser stimulation shortened the duration of 
REM sleep episodes (n=3 mice, P=0.008, paired t-test). Error bar, ±s.d. c, Probability of 
wake (left), NREM (middle), and REM (right) states before, during, and after laser 
stimulation (20 Hz, 120 s) at different laser powers (color coded).
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Extended Data Figure 4. Effect of laser stimulation of vM GABAergic neurons on transition 
probability between each pair of brain states in ChR2 (a-f) and eYFP control (g-l) mice
a, Probability of NREM (N)→REM (R) state transition within each 20 s period in ChR2 
mice. Blue shading, period of laser stimulation (20 Hz, 120 s). Error bar, ± s.d. (bootstrap, 
n=6 mice). Baseline transition probability (red dashed line) was computed after excluding 
the laser stimulation period. The probability during laser stimulation was significantly higher 
than the baseline (P=0.02, bootstrap). b, Similar to (a), for NREM→wake (W) transition. 
The probability during laser stimulation was not significantly different from baseline 
(P=0.24). c, REM → wake, probability during laser stimulation was significantly lower than 
baseline (P<0.001), consistent with the effect of vM GABAergic neurons on prolonging 
REM duration (Fig. 2). d, REM→NREM, which rarely occurs in rodents. Laser stimulation 
caused no significant effect (P>0.99). e, Wake→REM, which rarely occurs in normal mice. 
Laser stimulation had no significant effect (P>0.99). f, Wake→NREM. Laser stimulation 
caused a significant reduction of the transition probability (P<0.001), indicating that during 
wakefulness vM GABAergic neuron activity has a wake-maintenance effect. g-l, Similar to 
(a-f), for eYFP control mice. Laser stimulation had no significant effect on any transition 
probability (P>0.05).
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Extended Data Figure 5. Pharmacogenetic inactivation of vM GABAergic neurons reduces REM 
sleep
a, Brain states in a control (vehicle injection) and a CNO session from an example mouse. 
The recording session started 20 min after vehicle or CNO injection. b, Probability of each 
brain state during the first 2.5 hrs of the recording session, following injection of vehicle 
(gray) or two dosages of CNO (different shades of blue). Error bar, ±s.e.m. (n=6 mice). *, 
P<0.05; **, P<0.01; one-way ANOVA with post hoc Dunnett's test. c, Similar to (b), but 
during the second half of the recording session (2.5 to 5 hrs). There was no significant 
difference between control and CNO at any dosage (P>0.12). d, Latency of first REM sleep 
episode (from the beginning of each recording session). e, Frequency of REM episodes 
during the first 2.5 hrs of the recording session. f, Duration of REM episodes during the first 
2.5 hrs of the session. The reduction of REM sleep caused by pharmacogenetic inactivation 
of vM GABAergic neurons appears to be due to the reduction of frequency rather than 
duration of REM episodes.
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Extended Data Figure 6. Optogenetic identification of vM GABAergic neurons
a, Left, reliability and temporal jitter of laser-evoked spikes in identified (blue) and 
unidentified (gray) units recorded in the vM. Note that the identified and unidentified units 
form two distinct clusters, with high reliability and low jitter for identified units. Dark/light 
symbols, data during 30/15 Hz laser stimulation. Middle, distribution of delays of laser-
evoked spiking for 21 identified GABAergic neurons. Delay is defined as timing of the first 
spike following each laser pulse. Right, distribution of correlation coefficient between laser-
evoked and spontaneous spike waveforms for all 21 identified vM GABAergic neurons. b, 
Fluorescence image of a coronal section showing the position of an electrolytic lesion at the 
end of the optrode tract (arrow). Blue, DAPI staining. c, Positions of the 21 identified vM 
GABAergic neurons from 5 mice. Each dot indicates one neuron. All 20 neurons with 
recording periods encompassing all three brain states showed maximal firing rates during 
REM sleep. The wakeful behavior during which the neuron showed the maximal firing rate 
is color-coded. Black, neurons for which the recording period did not include all wakeful 
behaviors. Schemes of brain sections adapted from Allen Mouse Brain Atlas (Website: © 
2015 Allen Institute for Brain Science. Allen Mouse Brain Atlas [Internet]. Available from: 
http://mouse.brain-map.org).
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Extended Data Figure 7. Activity of vM GABAergic neurons at REM sleep onset and offset
a, Mean firing rates of vM GABAergic neurons at REM onset. Shading, ±s.e.m. Dark blue, 
period in which firing rate was significantly higher than baseline (P<0.05, Wilcoxon signed-
rank test); baseline was defined as the average firing rate during the 10 s intervals 60 s 
before and after REM sleep. b, Mean firing rates at REM offset.
Extended Data Figure 8. Effect of laser stimulation of vM neurons on several wakeful behaviors
a, Probability of moving (MV), running (RU), eating (ET), and grooming (GR) before, 
during, and after laser stimulation (20 Hz, 120 s) in GAD2-Cre mice injected with AAV 
expressing ChR2-eYFP into the vM (n=8 mice). Unclassified behaviors are not shown. Blue 
bar, period of laser stimulation. Laser stimulation caused a significant increase in eating 
(P=0.008, Wilcoxon signed-rank test). b, Similar to a, but in control mice expressing eYFP 
(n=4 mice).
Extended Data Figure 9. Firing rates of unidentified vM neurons
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a, Firing rates of unidentified units in the three brain states. Each line represents data from 
one neuron. Gray bar represents average over units (n=24). b, Left, relative firing rates of the 
units across brain states. The firing rates of each unit were normalized by its maximum. 
Right, normalized firing rates across different wakeful behaviors. c, Mean firing rates of 
unidentified vM neurons at REM onset. Shading, ±s.e.m. Dark blue, period in which firing 
rate was significantly higher than baseline (P<0.05, Wilcoxon signed-rank test). d, Mean 
firing rates of unidentified vM neurons at REM offset.
Extended Data Figure 10. Co-expression of GABA and glycine in vM neurons
a, Fluorescence image of ChR2-eYFP expressing neurons in the vM of a GAD2-Cre mouse 
injected with Cre-inducible AAV. b, Immunohistochemical staining for glycine. c, 
Superposition of eYFP-expression and glycine staining. In total, 94% (273/289) of eYFP-
expressing cells were glycine positive (n=3 mice).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Optogenetic activation of vM GABAergic neurons induces REM sleep
a, Top, schematic of optogenetic experiment (adapted from Paxinos and Franklin mouse 
brain atlas). Bottom, fluorescence image of vM (dashed box in schematic) in a GAD2-Cre 
mouse injected with AAV expressing ChR2-eYFP (green). Blue, DAPI. GI, gigantocellular 
reticular nucleus; LPGI, lateral paragigantocellular nucleus; IO, inferior olive; Amb, 
ambiguus nucleus. ChR2-eYFP was expressed within ~400 μm from injection site and 
mainly localized within the LPGI. b, Example experiment. Shown are EEG power 
spectrogram, EMG amplitude, and brain states (color coded). Blue shading, laser stimulation 
period (20 Hz, 120 s). c, Brain states in all trials from 6 mice (top) and probability of wake, 
NREM or REM states (bottom) before, during, and after laser stimulation. Shading, 95% 
confidence intervals (CI). Blue bar, laser stimulation period. d, Similar to (c), for trials with 
laser onset falling on NREM sleep (probability of NREM is 1 immediately before laser 
onset). e, Trials with laser onset falling on wakefulness.
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Figure 2. Activation of vM GABAergic neurons prolongs REM sleep duration
a, Schematic of closed-loop stimulation. Laser was turned on after spontaneous REM onset 
and turned off at REM termination. b, Example recording containing REM episodes with 
and without laser stimulation (blue shading). c, Mean REM sleep duration with and without 
laser stimulation, in ChR2 (left, n=6 mice) and eYFP control mice (right, n=4). Each pair of 
dots, data from one mouse. Error bar, ±s.d. d, Similar to (c), but with green laser stimulation 
in Arch/Halo (left, n=4 mice) and eYFP control (right, n=4) mice.
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Figure 3. Firing rates of identified vM GABAergic neurons across brain states
a, Example recording of spontaneous and laser-evoked spikes from a vM neuron. Blue ticks, 
laser pulses (30 Hz). b, Comparison between laser-evoked (blue) and averaged spontaneous 
(red) spike waveforms from this unit. c, Spike raster showing multiple trials of laser 
stimulation at 15 and 30 Hz. d, Firing rates of an example vM GABAergic neuron. e, Left, 
mean firing rates of the neuron in (d) during different brain states. Error bar, ±s.e.m. Right, 
firing rates of the neuron during different wakeful behaviors. f, Firing rates of 20 identified 
vM GABAergic neurons during different brain states. Each line shows firing rates of one 
unit; gray bar, average across units. g, Relative firing rates across brain states. The rates of 
each neuron were normalized by its maximum. All 20 neurons showed maximum firing rates 
during REM sleep (the difference was significant at P<0.005 for all 20 neurons compared to 
NREM and wakefulness; Wilcoxon rank sum test, post-hoc Bonferroni correction). h, 
Relative firing rates of 17 vM GABAergic neurons during different wakeful behaviors.
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Figure 4. Inhibition of vlPAG GABAergic neurons by vM projections promotes REM sleep
a, Top, schematic showing injection of AAV expressing ChR2-eYFP into the vM of a 
GAD2-Cre mouse. Bottom, fluorescence image of vM axons in the pons and midbrain 
(position of coronal section indicated by dashed line in schematic). Scale bar, 500 μm; 
Green, eYFP; Blue, DAPI. b, Top, schematic showing simultaneous injections of 
RetroBeads (RB) in the pons and FluoroGold (FG) in the spinal cord. Bottom, fluorescence 
image of vM, showing neurons labeled by RB and FG. Among the 1235 FG- and 881 RB-
labeled neurons, only 27 were double labeled. Scale bar, 500 μm. c, Left, probability of 
wake, NREM or REM states before, during, and after laser stimulation of vlPAG 
GABAergic neurons (20 Hz, 300 s; n=6 mice). Shading, 95% CI; Blue bar, laser stimulation 
period (20 Hz, 300s). Right, mean REM durations with and without vlPAG stimulation (n=5 
mice). Each pair of dots, data from one mouse. Error bar, ±s.d. d, Left, schematic showing 
rabies-mediated transsynaptic tracing. TVA, EnvA receptor; G, rabies glycoprotein; RVdG, 
G-deleted rabies virus. Middle, fluorescence image of vlPAG in a GAD2-Cre mouse. Scale 
bar, 500 μm. Bottom middle, enlarged view of region in white box showing starter cells 
(yellow, expressing both GFP and mCherry, arrowheads; Scale bar, 20 μm). Right, rabies-
labeled presynaptic neurons in vM (same brain as in middle panel). Scale bar, 500 μm. e, 
Rabies-labeled presynaptic neurons in vM are GABAergic and glycinergic. Lower panel, 
enlarged view of region in white box, containing GFP labeled neurons expressing glycine 
(Gly, arrowheads; Scale bar, 50 μm). GABA and glycine co-exist in a high percentage of vM 
neurons (Extended Data Fig. 10), suggesting that the glycinergic rabies-labeled neurons in 
the vM are also GABAergic. In total, 82% (185/226) rabies-labeled cells were glycine 
positive (n=3 mice). f, Left, probability of wake, NREM or REM states before, during, and 
after laser stimulation of vM axons in vlPAG (20 Hz, 120 s; n=5 mice). Shading, 95% CI. 
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Right, mean REM durations with and without vM axon stimulation (n=5 mice). Error bar, ± 
s.d.
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